Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Specific cyclooxygenase-2 (COX-2) inhibitors.

B R Rubin1

  • 1Department of Internal Medicine, University of North Texas Health Science Center, Fort Worth/Texas College of Osteopathic Medicine 76107, USA. brubin@hsc.unt.edu

The Journal of the American Osteopathic Association
|July 16, 1999
PubMed
Summary

Nonsteroidal anti-inflammatory drugs (NSAIDs) offer pain relief but can cause side effects. New COX-2 inhibitors provide arthritis treatment with potentially reduced gastrointestinal risks.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy and safety of etoricoxib 30 mg and celecoxib 200 mg in the treatment of osteoarthritis in two identically designed, randomized, placebo-controlled, non-inferiority studies.

Rheumatology (Oxford, England)·2006
Same author

Oral polymeric N-acetyl-D-glucosamine and osteoarthritis.

The Journal of the American Osteopathic Association·2001
Same author

Osteoarthritis.

The Journal of the American Osteopathic Association·2001
Same author

Encephalitis in New York.

Lancet (London, England)·2000
Same author

Gastropathy induced by nonsteroidal anti-inflammatory drugs: prescribing patterns among geriatric practitioners.

The Journal of the American Osteopathic Association·1999
Same author

Alendronate useful in treating osteoporosis.

The Journal of the American Osteopathic Association·1997

Area of Science:

  • Pharmacology and Therapeutics
  • Gastroenterology
  • Rheumatology

Background:

  • Nonsteroidal anti-inflammatory drugs (NSAIDs) are widely prescribed globally for pain and inflammation.
  • NSAIDs are associated with significant gastrointestinal, renal, and hemostatic side effects.
  • Recent research has elucidated the mechanisms behind NSAID efficacy and toxicity.

Purpose of the Study:

  • To review new insights into the therapeutic benefits and side effects of NSAIDs.
  • To discuss the development and clinical application of cyclooxygenase-2 (COX-2) specific inhibitors.

Main Methods:

  • Review of recent scientific literature on NSAID mechanisms and clinical trials.
  • Analysis of the role of cyclooxygenase (COX) enzyme isoforms (COX-1 and COX-2) in prostaglandin synthesis.
  • Evaluation of clinical data for newly available COX-2 selective inhibitors.

Main Results:

  • Discovery of two cyclooxygenase (COX) enzyme forms involved in prostaglandin metabolism.
  • Development and clinical trials of drugs specifically inhibiting the COX-2 enzyme.
  • Availability of COX-2 inhibitors in the United States for patient treatment.

Conclusions:

  • Specific COX-2 inhibitors demonstrate potential for treating arthritis pain and inflammation.
  • These newer agents may offer reduced risk of serious gastrointestinal injury compared to traditional NSAIDs.
  • Advancements in understanding COX pathways have led to targeted anti-inflammatory therapies.

Related Experiment Videos